TY - JOUR
T1 - Maitotoxin, a novel activator of mediator release from human basophils, induces large increases in cytosolic calcium resulting in histamine, but not leukotriene C4, release
AU - Columbo, M.
AU - Taglialatela, M.
AU - Warner, J. A.
AU - MacGlashan, D. W.
AU - Yasumoto, T.
AU - Annunziato, L.
AU - Marone, G.
PY - 1992
Y1 - 1992
N2 - Maitotoxin (MTX) is a potent marine toxin which stimulates several Ca++- dependent processes presumably through an increase in Ca++ permeability. We have examined the effect of MTX on the release of chemical mediators from human basophils and its mechanism of action. MTX (1-20 ng/ml) induced histamine release (37-100%) from both mixed leukocyte preparations and purified basophils. Histamine release activated by MTX was slow (t( 1/2 ) ≃ 15 min), temperature and Ca++ dependent (optimal at 37°C and 1-2.5 mM Ca++). Sr++ ion could substitute for Ca++ in the secretory process. Digital video microscopy analysis of purified (>70%) basophils revealed that MTX (1-20 ng/ml) induced a slow and marked increase of cytosolic Ca++ levels that was temporally coincident with histamine release. MTX (1-20 ng/ml) stimulated the release of sulfidopeptide leukotriene C4 from mixed leukocyte preparations (≃0.5% basophils). However, purified basophils (77 ± 7%) showed no sulfidopeptide leukotriene C4 release even in the presence of large histamine secretion (84 ± 14%). Two organic Ca++-channel entry blockers, verapamil and diltiazem (1-30 μM) inhibited the release of histamine induced by MTX, whereas the dihydropyridine nifedipine (0.1-10 μM) caused only minimal inhibition. These results suggest that MTX represents a novel stimulus useful to study the role of Ca++ in human basophil mediator release.
AB - Maitotoxin (MTX) is a potent marine toxin which stimulates several Ca++- dependent processes presumably through an increase in Ca++ permeability. We have examined the effect of MTX on the release of chemical mediators from human basophils and its mechanism of action. MTX (1-20 ng/ml) induced histamine release (37-100%) from both mixed leukocyte preparations and purified basophils. Histamine release activated by MTX was slow (t( 1/2 ) ≃ 15 min), temperature and Ca++ dependent (optimal at 37°C and 1-2.5 mM Ca++). Sr++ ion could substitute for Ca++ in the secretory process. Digital video microscopy analysis of purified (>70%) basophils revealed that MTX (1-20 ng/ml) induced a slow and marked increase of cytosolic Ca++ levels that was temporally coincident with histamine release. MTX (1-20 ng/ml) stimulated the release of sulfidopeptide leukotriene C4 from mixed leukocyte preparations (≃0.5% basophils). However, purified basophils (77 ± 7%) showed no sulfidopeptide leukotriene C4 release even in the presence of large histamine secretion (84 ± 14%). Two organic Ca++-channel entry blockers, verapamil and diltiazem (1-30 μM) inhibited the release of histamine induced by MTX, whereas the dihydropyridine nifedipine (0.1-10 μM) caused only minimal inhibition. These results suggest that MTX represents a novel stimulus useful to study the role of Ca++ in human basophil mediator release.
UR - http://www.scopus.com/inward/record.url?scp=0026992064&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026992064&partnerID=8YFLogxK
M3 - Article
C2 - 1281881
AN - SCOPUS:0026992064
VL - 263
SP - 979
EP - 986
JO - Journal of Pharmacology and Experimental Therapeutics
JF - Journal of Pharmacology and Experimental Therapeutics
SN - 0022-3565
IS - 3
ER -